Biotecnología y Biología Sintética
Programmation du vivant : CRISPR, protein design, biofoundries, biomaterials
Overview
Programmation et engineering du vivant. CRISPR thérapies géno, protéines designées, fermentation biologique, matériaux bio inspirés.
Impact : Cure de maladies génétiques, bioproduction échelle exajoule, nouveaux matériaux, zéro-waste manufacturing
Projects
Active
Editas Medicine — CRISPR Gene Therapy
Pipeline 20+ indications. First approvals 2024-2025, expansion agressive 2026+.
52% — 2025-2026
DeepMind — AlphaFold & Protein Design
AlphaFold tous les problèmes. Drug discovery acceleration massif. Therapeutics custom-designed.
65% — 2027-2028
Intrexon (Precigen) — Biomanufacturing
Bio-manufacturing scale. Chemicals, fuels, materials via fermentation optimized.
48% — 2027-2028
Mylo & Bolt Threads — Biomaterials
Production de matériaux impossibles via fermentation. Mode durable, haute performance.
58% — 2026-2027
Genentech & Collaborators — mRNA Therapeutics
Expansion au-delà COVID. RSV approval, influenza clinical data, cancer vaccines Phase 2/3.
55% — 2026-2027